Study Shows Tocilizumab Reduces Mortality in Critically-Ill COVID-19 Patients
Oct 20, 2020 PM EDT
Contrary to the steroids, which more extensively suppress the immune system, tocilizumab particularly stops the pro-inflammatory cytokine receptor, IL-6.
